WO2001073017A3 - Regulation of human adp-ribosylation factor-related protein - Google Patents

Regulation of human adp-ribosylation factor-related protein Download PDF

Info

Publication number
WO2001073017A3
WO2001073017A3 PCT/EP2001/003431 EP0103431W WO0173017A3 WO 2001073017 A3 WO2001073017 A3 WO 2001073017A3 EP 0103431 W EP0103431 W EP 0103431W WO 0173017 A3 WO0173017 A3 WO 0173017A3
Authority
WO
WIPO (PCT)
Prior art keywords
related protein
regulation
ribosylation factor
human adp
adp
Prior art date
Application number
PCT/EP2001/003431
Other languages
French (fr)
Other versions
WO2001073017A2 (en
Inventor
Jiing-Ren Liou
Original Assignee
Bayer Ag
Jiing-Ren Liou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Jiing-Ren Liou filed Critical Bayer Ag
Priority to AU2001250405A priority Critical patent/AU2001250405A1/en
Publication of WO2001073017A2 publication Critical patent/WO2001073017A2/en
Publication of WO2001073017A3 publication Critical patent/WO2001073017A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Human ADP-ribosylation factor-related protein can be regulated to treat or prevent diseases involving signaling, growth, immunity, and protein transport.
PCT/EP2001/003431 2000-03-27 2001-03-27 Regulation of human adp-ribosylation factor-related protein WO2001073017A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001250405A AU2001250405A1 (en) 2000-03-27 2001-03-27 Regulation of human adp-ribosylation factor-related protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19237300P 2000-03-27 2000-03-27
US60/192,373 2000-03-27

Publications (2)

Publication Number Publication Date
WO2001073017A2 WO2001073017A2 (en) 2001-10-04
WO2001073017A3 true WO2001073017A3 (en) 2002-10-10

Family

ID=22709378

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/003431 WO2001073017A2 (en) 2000-03-27 2001-03-27 Regulation of human adp-ribosylation factor-related protein

Country Status (2)

Country Link
AU (1) AU2001250405A1 (en)
WO (1) WO2001073017A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115807016B (en) * 2022-11-22 2024-05-10 西南大学 Application of Bna.arf gene of brassica napus in improving plant biomass

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999067377A1 (en) * 1998-06-23 1999-12-29 Incyte Pharmaceuticals, Inc. Human arf-related proteins
WO2000012702A2 (en) * 1998-08-31 2000-03-09 Bayer Corporation Human genes differentially expressed in colorectal cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999067377A1 (en) * 1998-06-23 1999-12-29 Incyte Pharmaceuticals, Inc. Human arf-related proteins
WO2000012702A2 (en) * 1998-08-31 2000-03-09 Bayer Corporation Human genes differentially expressed in colorectal cancer

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BREINER M ET AL: "Cloning of a novel member (ARL5) of the ARF-family of Ras-related GTPases.", BIOCHIMICA ET BIOPHYSICA ACTA. NETHERLANDS 31 JUL 1996, vol. 1308, no. 1, 31 July 1996 (1996-07-31), pages 1 - 6, XP002933784, ISSN: 0006-3002 *
DATABASE EMBL [online] 14 June 2000 (2000-06-14), ENDEGE WO ET AL.: "Human colon cancer differentially expressed nucleotide sequence #31", XP002207158, retrieved from E.B.I., HINXTON, UK Database accession no. AAA16026 *
DATABASE EMBL [online] 18 April 2000 (2000-04-18), HILLMAN JL ET AL.: "Human ARF-related protein-2 (HARP-2) encoding cDNA", XP002207157, retrieved from E.B.I., HINXTON, UK Database accession no. AAZ49769 *
INGLEY E ET AL: "A novel ADP-ribosylation like factor (ARL-6), interacts with the protein-conducting channel SEC61beta subunit.", FEBS LETTERS. NETHERLANDS 1 OCT 1999, vol. 459, no. 1, 1 October 1999 (1999-10-01), pages 69 - 74, XP004260320, ISSN: 0014-5793 *
JACOBS S ET AL: "ADP-ribosylation factor (ARF)-like 4, 6, and 7 represent a subgroup of the ARF family characterized by rapid nucleotide exchange and a nuclear localization signal", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 456, no. 3, 13 August 1999 (1999-08-13), pages 384 - 388, XP004260102, ISSN: 0014-5793 *

Also Published As

Publication number Publication date
WO2001073017A2 (en) 2001-10-04
AU2001250405A1 (en) 2001-10-08

Similar Documents

Publication Publication Date Title
HK1048831A1 (en) Human ctla-4 antibodies and their uses
WO2001045679A3 (en) Use of chemotherapeutic agents for topical treatment
MXPA03007816A (en) Disposable underpants and method of providing the same.
HRP20020593B1 (en) Brain, spinal and nerve injury treatment
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
DE59509848D1 (en) COMBINATION PRODUCT FOR USE IN IMMUNOLOGICAL DISEASES
WO2001091772A3 (en) Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
AU2001264769A1 (en) Induction of apoptosis and cell growth inhibition by protein 4.33
DE50114605D1 (en) NO-THIEN-2-YL-VINEGAR DERIVATIVES AND THEIR USE FOR THE TREATMENT OF MIGRAINE BZW. PAIN
WO2003063725A3 (en) Methods of preventing and treating flavivirus infection in animals
AU2001258373A1 (en) Method for identifying helicobacter antigens
WO2001055111A8 (en) Biaryl compounds, their preparation and their use in therapy
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
ZA200203008B (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.
AU1777301A (en) Production of ungulates, preferably bovines that produce human immunoglobulins
MXPA03003309A (en) Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin.
WO2001073017A3 (en) Regulation of human adp-ribosylation factor-related protein
EP1318819A4 (en) Treatment of trauma, and other indications
AU2002365083A8 (en) Composition and method to treat viral bacterial and parasitic infections and infestations
WO2001091766A3 (en) Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
DE60124093D1 (en) S-methyl-dihydro-ziprasidone for the treatment of eye diseases.
GB2374871A (en) Peptide fragments of colostrinin and their use
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP